33
Views
0
CrossRef citations to date
0
Altmetric
Patenting Perspective

Personalized medicine: impact of subject matter and utility requirements on patentability in the United States

, , PhD JD
Pages 1275-1282 | Published online: 16 Oct 2007
 

Abstract

Personalized medicine is a relatively new field that recognizes and takes advantage of a patient's individual genetic and physiologic make-up, as well as specific environmental influences. Obtaining and defending patents this field, however, can raise legal issues, such as those relating to ‘subject matter’ patentability and ‘utility,’ two requirements under US law. This perspective article provides an analysis of certain US patent cases relevant to these requirements, including Lab. Corp. v. Metabolite pertaining to subject matter patentability of certain types of diagnostic methods, and In re Fisher addressing the utility of certain DNA-related research tools. Understanding such cases can provide guidance as to how to avoid certain pitfalls when preparing, prosecuting and defending patents in the field of personalized medicine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.